Search Results - "SZETO, Linda"

Refine Results
  1. 1

    Exenatide, a Glucagon-like Peptide-1 Receptor Agonist, Acutely Inhibits Intestinal Lipoprotein Production in Healthy Humans by Xiao, Changting, Bandsma, Robert H J, Dash, Satya, Szeto, Linda, Lewis, Gary F

    “…OBJECTIVES—Incretin-based therapies for the treatment of type 2 diabetes mellitus improve plasma lipid profiles and postprandial lipemia, but their exact…”
    Get full text
    Journal Article
  2. 2

    Insulin Acutely Inhibits Intestinal Lipoprotein Secretion in Humans in Part by Suppressing Plasma Free Fatty Acids by PAVLIC, Mirjana, CHANGTING XIAO, SZETO, Linda, PATTERSON, Bruce W, LEWIS, Gary F

    Published in Diabetes (New York, N.Y.) (01-03-2010)
    “…Intestinal lipoprotein production has recently been shown to be increased in insulin resistance, but it is not known whether it is regulated by insulin in…”
    Get full text
    Journal Article
  3. 3

    Both Intestinal and Hepatic Lipoprotein Production Are Stimulated by an Acute Elevation of Plasma Free Fatty Acids in Humans by DUEZ, Hélène, LAMARCHE, Benoit, VALERO, René, PAVLIC, Mirjana, PROCTOR, Spencer, CHANGTING XIAO, SZETO, Linda, PATTERSON, Bruce W, LEWIS, Gary F

    Published in Circulation (New York, N.Y.) (06-05-2008)
    “…Hepatic lipoprotein production has been shown previously to be regulated by free fatty acid (FFA) flux to the liver, whereas intestinal lipoprotein production…”
    Get full text
    Journal Article
  4. 4

    Intestinal Lipoprotein Overproduction, a Newly Recognized Component of Insulin Resistance, Is Ameliorated by the Insulin Sensitizer Rosiglitazone: Studies in the Fructose-Fed Syrian Golden Hamster by Lewis, Gary F, Uffelman, Kristine, Naples, Mark, Szeto, Linda, Haidari, Mehran, Adeli, Khosrow

    Published in Endocrinology (Philadelphia) (01-01-2005)
    “…We investigated whether intestinal lipoprotein overproduction in a fructose-fed, insulin-resistant hamster model is prevented with insulin sensitization…”
    Get full text
    Journal Article
  5. 5

    Atorvastatin induces insulin sensitization in Zucker lean and fatty rats by Wong, Victor, Stavar, Laura, Szeto, Linda, Uffelman, Kristine, Wang, Chao-Hung, Fantus, I George, Lewis, Gary F.

    Published in Atherosclerosis (01-02-2006)
    “…The 3-hydroxy-3-methyl glutaryl coenzyme A (HMG-CoA) reductase inhibitors (‘statins’) have been implicated in preventing new onset type 2 diabetes, whereas the…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    Intestinal Lipoprotein Production Is Stimulated by an Acute Elevation of Plasma Free Fatty Acids in the Fasting State: Studies in Insulin-Resistant and Insulin-Sensitized Syrian Golden Hamsters by Lewis, Gary F, Naples, Mark, Uffelman, Kristine, Leung, Nathalie, Szeto, Linda, Adeli, Khosrow

    Published in Endocrinology (Philadelphia) (01-11-2004)
    “…It is not known whether intestinal lipoprotein production is stimulated by an acute elevation of plasma free fatty acids (FFA). We examined the effect of an…”
    Get full text
    Journal Article
  9. 9

    Effects of acute hyperinsulinemia on VLDL triglyceride and VLDL ApoB production in normal weight and obese individuals by LEWIS, G. F, UFFELMAN, K. D, SZETO, L. W, STEINER, G

    Published in Diabetes (New York, N.Y.) (01-06-1993)
    “…The effects of short-term hyperinsulinemia on the production of both VLDL triglyceride and VLDL apoB were determined semiquantitatively before and during a 6-h…”
    Get full text
    Journal Article
  10. 10

    Enhancement of muscle glucose uptake by the vasopeptidase inhibitor, omapatrilat, is independent of insulin signaling and the AMP kinase pathway by Wong, Victor, Szeto, Linda, Uffelman, Kristine, Fantus, I George, Lewis, Gary F

    Published in Journal of endocrinology (01-08-2006)
    “…Omapatrilat (OMA), a vasopeptidase inhibitor (VPI), presently being tested in clinical trials for its antihypertensive properties, inhibits both…”
    Get full text
    Journal Article
  11. 11

    High-Dose Resveratrol Treatment for 2 Weeks Inhibits Intestinal and Hepatic Lipoprotein Production in Overweight/Obese Men by Dash, Satya, Xiao, Changting, Morgantini, Cecilia, Szeto, Linda, Lewis, Gary F

    “…OBJECTIVE—Overproduction of hepatic apolipoprotein B (apoB)-100 containing very low-density lipoprotein particles and intestinal apoB-48 containing…”
    Get full text
    Journal Article
  12. 12

    Effects of Acute Hyperglucagonemia on Hepatic and Intestinal Lipoprotein Production and Clearance in Healthy Humans by CHANGTING XIAO, PAVLIC, Mirjana, SZETO, Linda, PATTERSON, Bruce W, LEWIS, Gary F

    Published in Diabetes (New York, N.Y.) (01-02-2011)
    “…The metabolism of hepatic- and intestinally derived lipoproteins is regulated in a complex fashion by nutrients, hormones, and neurologic and other factors…”
    Get full text
    Journal Article
  13. 13

    Triglyceride-Rich Lipoprotein-Associated Apolipoprotein C-III Production Is Stimulated by Plasma Free Fatty Acids in Humans by Pavlic, Mirjana, Valéro, René, Duez, Hélène, Xiao, Changting, Szeto, Linda, Patterson, Bruce W, Lewis, Gary F

    “…OBJECTIVE—Insulin resistant states are associated with increased fatty acid flux to liver and intestine, which stimulates the production of triglyceride-rich…”
    Get full text
    Journal Article
  14. 14

    Partial characterization of the fructose-induced defect in very-low-density lipoprotein triglyceride metabolism by Mamo, J C, Hirano, T, James, L, Szeto, L, Steiner, G

    Published in Metabolism, clinical and experimental (01-09-1991)
    “…Very-low-density lipoprotein triglyceride (VLDL-TG) catabolism was studied in rats receiving either fructose or glucose as a 10% drinking solution. Consumption…”
    Get more information
    Journal Article
  15. 15
  16. 16

    Acute Dipeptidyl Peptidase-4 Inhibition Rapidly Enhances Insulin-Mediated Suppression of Endogenous Glucose Production in Mice by Duez, Hélène, Smith, Angela C, Xiao, C, Giacca, Adria, Szeto, Linda, Drucker, Daniel J, Lewis, Gary F

    Published in Endocrinology (Philadelphia) (01-01-2009)
    “…Pharmacological approaches that enhance incretin action for the treatment of type 2 diabetes mellitus have recently been developed, i.e. injectable…”
    Get full text
    Journal Article
  17. 17

    Interaction between free fatty acids and insulin in the acute control of very low density lipoprotein production in humans by Lewis, G F, Uffelman, K D, Szeto, L W, Weller, B, Steiner, G

    Published in The Journal of clinical investigation (01-01-1995)
    “…Changes in VLDL triglyceride and VLDL apo B production were determined semiquantitatively in healthy young men by examining the effect of altering plasma…”
    Get full text
    Journal Article
  18. 18

    Dissociation between the Insulin-Sensitizing Effect of Rosiglitazone and Its Effect on Hepatic and Intestinal Lipoprotein Production by Duez, Hélène, Lamarche, Benoît, Uffelman, Kristine D., Valéro, René, Szeto, Linda, Lemieux, Simone, Cohn, Jeffrey S., Lewis, Gary F.

    “…Context: Despite its potent, well-documented insulin-sensitizing effects, rosiglitazone (RSG) does not effectively ameliorate the hypertriglyceridemia of…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Rosiglitazone improves intestinal lipoprotein overproduction in the fat-fed Syrian Golden hamster, an animal model of nutritionally-induced insulin resistance by Leung, Nathalie, Naples, Mark, Uffelman, Kristine, Szeto, Linda, Adeli, Khosrow, Lewis, Gary F

    Published in Atherosclerosis (01-06-2004)
    “…We have recently shown that the fructose-fed Syrian Golden hamster, a non-diabetic animal model of nutritionally-induced insulin resistance and hyperlipidemia,…”
    Get full text
    Journal Article